CVE-2022-37461: n/a in n/a
Multiple cross-site scripting (XSS) vulnerabilities in Canon Medical Vitrea View 7.x before 7.7.6 allow remote attackers to inject arbitrary web script or HTML via (1) the input after the error subdirectory to the /vitrea-view/error/ subdirectory, or the (2) groupID, (3) offset, or (4) limit parameter to an Administrative Panel (Group and Users) page. There is a risk of an attacker retrieving patient information.
AI Analysis
Technical Summary
CVE-2022-37461 is a medium-severity vulnerability involving multiple cross-site scripting (XSS) flaws in Canon Medical Vitrea View versions prior to 7.7.6. The affected software is a medical imaging viewer platform used for diagnostic purposes. The vulnerability arises from insufficient input validation and output encoding in several web interface components. Specifically, attackers can inject arbitrary web scripts or HTML via the input after the error subdirectory in the /vitrea-view/error/ path, as well as through the groupID, offset, or limit parameters in the Administrative Panel's Group and Users pages. Exploiting these XSS vulnerabilities requires no authentication but does require user interaction, such as an administrator or user clicking a crafted link or visiting a malicious page. The vulnerability allows attackers to execute malicious scripts in the context of the victim's browser session, potentially leading to theft of session cookies, unauthorized actions, or retrieval of sensitive patient information displayed within the application. The CVSS 3.1 base score is 6.1, reflecting network attack vector, low attack complexity, no privileges required, user interaction required, and partial confidentiality and integrity impact but no availability impact. No known exploits have been reported in the wild, and no official patches or mitigation links were provided in the source information, though upgrading to version 7.7.6 or later is implied as a remediation step. The underlying weakness corresponds to CWE-79, which is a common web application security issue related to improper neutralization of input leading to XSS.
Potential Impact
For European organizations, especially healthcare providers and medical imaging centers using Canon Medical Vitrea View, this vulnerability poses a significant risk to patient data confidentiality and system integrity. Successful exploitation could allow attackers to steal sensitive patient information, manipulate administrative functions, or conduct further attacks within the network by leveraging stolen session credentials. Given the critical nature of healthcare data under GDPR, any data breach could lead to regulatory penalties, reputational damage, and loss of patient trust. Additionally, unauthorized administrative actions could disrupt medical workflows or compromise diagnostic accuracy. The risk is heightened in environments where the affected software is accessible over the network and used by multiple administrative users. Although the vulnerability does not directly impact system availability, the indirect consequences of data leakage and unauthorized access could be severe for healthcare operations in Europe.
Mitigation Recommendations
European healthcare organizations should prioritize upgrading Canon Medical Vitrea View to version 7.7.6 or later, where these XSS vulnerabilities are addressed. In the absence of immediate patching, organizations should implement strict input validation and output encoding on all web interface parameters, particularly those identified (error subdirectory input, groupID, offset, limit). Employing web application firewalls (WAFs) with custom rules to detect and block suspicious script injection attempts targeting these parameters can provide interim protection. Additionally, restricting access to the Administrative Panel to trusted networks and enforcing multi-factor authentication reduces the risk of exploitation. Security awareness training for administrative users to recognize phishing or malicious links can mitigate user interaction risks. Regular security assessments and penetration testing focused on web interface vulnerabilities should be conducted to detect similar issues proactively. Finally, monitoring logs for unusual access patterns or script injection attempts can help identify exploitation attempts early.
Affected Countries
Germany, France, United Kingdom, Italy, Spain, Netherlands, Sweden, Belgium, Switzerland, Austria
CVE-2022-37461: n/a in n/a
Description
Multiple cross-site scripting (XSS) vulnerabilities in Canon Medical Vitrea View 7.x before 7.7.6 allow remote attackers to inject arbitrary web script or HTML via (1) the input after the error subdirectory to the /vitrea-view/error/ subdirectory, or the (2) groupID, (3) offset, or (4) limit parameter to an Administrative Panel (Group and Users) page. There is a risk of an attacker retrieving patient information.
AI-Powered Analysis
Technical Analysis
CVE-2022-37461 is a medium-severity vulnerability involving multiple cross-site scripting (XSS) flaws in Canon Medical Vitrea View versions prior to 7.7.6. The affected software is a medical imaging viewer platform used for diagnostic purposes. The vulnerability arises from insufficient input validation and output encoding in several web interface components. Specifically, attackers can inject arbitrary web scripts or HTML via the input after the error subdirectory in the /vitrea-view/error/ path, as well as through the groupID, offset, or limit parameters in the Administrative Panel's Group and Users pages. Exploiting these XSS vulnerabilities requires no authentication but does require user interaction, such as an administrator or user clicking a crafted link or visiting a malicious page. The vulnerability allows attackers to execute malicious scripts in the context of the victim's browser session, potentially leading to theft of session cookies, unauthorized actions, or retrieval of sensitive patient information displayed within the application. The CVSS 3.1 base score is 6.1, reflecting network attack vector, low attack complexity, no privileges required, user interaction required, and partial confidentiality and integrity impact but no availability impact. No known exploits have been reported in the wild, and no official patches or mitigation links were provided in the source information, though upgrading to version 7.7.6 or later is implied as a remediation step. The underlying weakness corresponds to CWE-79, which is a common web application security issue related to improper neutralization of input leading to XSS.
Potential Impact
For European organizations, especially healthcare providers and medical imaging centers using Canon Medical Vitrea View, this vulnerability poses a significant risk to patient data confidentiality and system integrity. Successful exploitation could allow attackers to steal sensitive patient information, manipulate administrative functions, or conduct further attacks within the network by leveraging stolen session credentials. Given the critical nature of healthcare data under GDPR, any data breach could lead to regulatory penalties, reputational damage, and loss of patient trust. Additionally, unauthorized administrative actions could disrupt medical workflows or compromise diagnostic accuracy. The risk is heightened in environments where the affected software is accessible over the network and used by multiple administrative users. Although the vulnerability does not directly impact system availability, the indirect consequences of data leakage and unauthorized access could be severe for healthcare operations in Europe.
Mitigation Recommendations
European healthcare organizations should prioritize upgrading Canon Medical Vitrea View to version 7.7.6 or later, where these XSS vulnerabilities are addressed. In the absence of immediate patching, organizations should implement strict input validation and output encoding on all web interface parameters, particularly those identified (error subdirectory input, groupID, offset, limit). Employing web application firewalls (WAFs) with custom rules to detect and block suspicious script injection attempts targeting these parameters can provide interim protection. Additionally, restricting access to the Administrative Panel to trusted networks and enforcing multi-factor authentication reduces the risk of exploitation. Security awareness training for administrative users to recognize phishing or malicious links can mitigate user interaction risks. Regular security assessments and penetration testing focused on web interface vulnerabilities should be conducted to detect similar issues proactively. Finally, monitoring logs for unusual access patterns or script injection attempts can help identify exploitation attempts early.
For access to advanced analysis and higher rate limits, contact root@offseq.com
Technical Details
- Data Version
- 5.1
- Assigner Short Name
- mitre
- Date Reserved
- 2022-08-07T00:00:00.000Z
- Cisa Enriched
- true
- Cvss Version
- 3.1
- State
- PUBLISHED
Threat ID: 682cd9834d7c5ea9f4b3768d
Added to database: 5/20/2025, 7:35:31 PM
Last enriched: 7/6/2025, 6:55:10 AM
Last updated: 7/31/2025, 11:04:36 PM
Views: 10
Related Threats
CVE-2025-9109: Observable Response Discrepancy in Portabilis i-Diario
MediumCVE-2025-9108: Improper Restriction of Rendered UI Layers in Portabilis i-Diario
MediumCVE-2025-9107: Cross Site Scripting in Portabilis i-Diario
MediumCVE-2025-9106: Cross Site Scripting in Portabilis i-Diario
MediumCVE-2025-9105: Cross Site Scripting in Portabilis i-Diario
MediumActions
Updates to AI analysis are available only with a Pro account. Contact root@offseq.com for access.
Need enhanced features?
Contact root@offseq.com for Pro access with improved analysis and higher rate limits.